Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

NCT05636904 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Androgenetic Alopecia

Interventions

DRUG: prostaglandin F2a analogue in vehicle solution high dose
DRUG: prostaglandin F2a analogue in vehicle solution low dose
DRUG: active ingredient-free vehicle solution to DLQ01
DRUG: Minoxidil 5% Topical Solution

Sponsor

Dermaliq Therapeutics, Inc.